Sale!

TMEM127 Gene Pheochromocytoma Type 8 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The TMEM127 Gene Pheochromocytoma Type 8 NGS Genetic DNA Test is a cutting-edge genetic screening that identifies mutations in the TMEM127 gene associated with hereditary pheochromocytoma type 8. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variants that significantly increase cancer risk. Individuals with family history of adrenal tumors, unexplained hypertension, or neuroendocrine cancers should consider this test. Early detection enables proactive monitoring and personalized prevention strategies. The test requires a simple blood sample or extracted DNA and provides results within 3-4 weeks. At only $500 USD, this test offers affordable access to advanced genetic cancer screening with professional genetic counseling included.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

TMEM127 Gene Pheochromocytoma Type 8 NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Cancer Risk

The TMEM127 Gene Pheochromocytoma Type 8 NGS Genetic DNA Test represents a breakthrough in precision medicine for individuals concerned about hereditary cancer syndromes. This advanced diagnostic tool specifically targets mutations in the TMEM127 gene, which plays a critical role in regulating cell growth and division. When this gene malfunctions, it significantly increases the risk of developing pheochromocytomas – rare tumors of the adrenal glands that can produce excessive amounts of catecholamines, leading to dangerous blood pressure fluctuations and cardiovascular complications.

What Does This Test Measure?

Our state-of-the-art NGS (Next-Generation Sequencing) technology comprehensively analyzes the entire TMEM127 gene to identify:

  • Point mutations and single nucleotide variants
  • Insertions and deletions (indels)
  • Copy number variations
  • Pathogenic and likely pathogenic variants
  • Variants of uncertain significance requiring further evaluation

The test achieves exceptional accuracy rates exceeding 99%, providing reliable results that guide clinical decision-making and personalized healthcare strategies.

Who Should Consider TMEM127 Genetic Testing?

Clinical Indications and Risk Factors

This genetic test is particularly recommended for individuals experiencing:

  • Unexplained or treatment-resistant hypertension
  • Episodic headaches, palpitations, or sweating episodes
  • Personal history of adrenal tumors or pheochromocytomas
  • Family history of neuroendocrine tumors or multiple endocrine neoplasia
  • Early-onset adrenal gland disorders
  • Multiple family members with similar endocrine conditions
  • Young individuals diagnosed with pheochromocytomas

Significant Benefits of TMEM127 Genetic Testing

Proactive Health Management

Undergoing TMEM127 genetic testing provides numerous advantages for your long-term health:

  • Early Detection: Identify genetic predisposition before symptoms develop
  • Personalized Screening: Establish appropriate monitoring protocols based on genetic risk
  • Family Planning: Make informed decisions about genetic inheritance
  • Treatment Guidance: Inform surgical and medical management strategies
  • Peace of Mind: Reduce uncertainty through definitive genetic information
  • Cost-Effective Prevention: Potentially avoid expensive emergency treatments through early intervention

Understanding Your Test Results

Comprehensive Result Interpretation

Your TMEM127 genetic test results will fall into one of several categories, each with specific clinical implications:

  • Positive Result: Indicates the presence of a known pathogenic variant in the TMEM127 gene. This confirms hereditary pheochromocytoma predisposition and necessitates regular monitoring and specialized care.
  • Negative Result: No pathogenic variants detected. While reassuring, this doesn’t completely eliminate cancer risk, as other genetic or environmental factors may contribute.
  • Variant of Uncertain Significance (VUS): A genetic change with unknown clinical significance. Regular follow-up and family studies may be recommended.

All results include detailed interpretation by our board-certified genetic counselors and clinical geneticists, ensuring you receive comprehensive guidance for next steps.

Test Information and Pricing

Test Component Details Price (USD)
Test Name TMEM127 Gene Pheochromocytoma Type 8 NGS Genetic DNA Test
Discount Price Limited Time Special Offer $500
Regular Price Standard Testing Fee $700
Turnaround Time Comprehensive Analysis Period 3-4 Weeks
Sample Type Blood, Extracted DNA, or FTA Card Blood Spot

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified genetic counselors and phlebotomists ensures accessible, professional service regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about your genetic cancer risk compromise your peace of mind. Our TMEM127 Gene Pheochromocytoma Type 8 NGS Genetic DNA Test provides the clarity and confidence you need to make informed healthcare decisions. With our limited-time discount of only $500 USD (regularly $700), there’s never been a better opportunity to invest in your genetic health.

Ready to schedule your test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Our dedicated specialists are available to answer your questions, discuss insurance coverage options, and guide you through the testing process with compassion and expertise.

Take the first step toward proactive cancer prevention and personalized healthcare management. Your genetic health journey begins with a single phone call.